NCT04417023View on ClinicalTrials.gov

B3 for NMD: Bench to Bedside and Back

UnknownOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

March 8, 2019

Primary Completion Date

October 31, 2023

Study Completion Date

March 31, 2024

Conditions
Neuromuscular Disease
Interventions
OTHER

B3 for NMD: Bench to Bedside and Back

Transformative discoveries leading to improved care in Neuromuscular Disease

Trial Locations (1)

K1Y4E9

RECRUITING

Ottawa Hospital Research Institute, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER